RecallRadar

FDA Drug recall D-0490-2015

0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira Inc., Lake Forest, IL, 60045, NDC: 0409-7101…

On 2015-04-29 the FDA classified a Class II recall of 0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira Inc., Lake Forest, IL, 60045, NDC: 0409-7101… by Hospira, citing lack of Sterility Assurance: The product has the potential to leak at the administrative port.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0490-2015
ClassificationClass II
Statusterminated
Initiated2015-04-07
Published2015-04-29
Last updated2026-09-13 11:51 UTC
CompanyHospira
DistributionUS

Product

0.9% Sodium Chloride Injection, USP, 100 mL ADD-Vantage Unit, Rx only, Manufactured by Hospira Inc., Lake Forest, IL, 60045, NDC: 0409-7101-67

Reason

Lack of Sterility Assurance: The product has the potential to leak at the administrative port.

Identifiers

ndc0409-7101-68
ndc0409-7101-66
ndc0409-7101-69
ndc0409-7101-67
ndc0409-7101-04
ndc0409-7101-02
ndc0409-7132-68
ndc0409-7132-66
ndc0409-7132-69
ndc0409-7132-67
ndc0409-7132-04
ndc0409-7132-02
code_infoLot# 44-110-JT; Exp 08/16

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0490-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.